Safety and tolerability of intensified, N-terminal pro brain natriuretic peptide-guided compared with standard medical therapy in elderly patients with congestive heart failure: results from TIME-CHF

Sandra Sanders-van Wijk*, Stefano Muzzarelli, Michael Neuhaus, Stephanie Kiencke, Micha Maeder, Werner Estlinbaum, Daniel Tobler, Kurt Mayer, Paul Erne, Matthias E. Pfisterer, Hans-Peter Brunner-La Rocca

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)910-918
JournalEuropean journal of heart failure
Volume15
Issue number8
DOIs
Publication statusPublished - Aug 2013

Keywords

  • Heart failure
  • Natriuretic peptide
  • Safety
  • Drug therapy
  • Ageing
  • Co-morbidities

Cite this